Preventive Medicine News

Patients who underwent lung cancer screening had a significant reduction in mortality associated with the disease, although it came with a “tradeoff” of likely overdiagnosis, according to a recent meta-analysis.

Editor’s note: One of the studies cited in this story, conducted in Egypt, has since been retracted. The FDA has not approved ivermectin for use in treating or preventing COVID-19. Moreover, the Infectious Diseases Society of America recommends against ivermectin for the treatment of outpatients with COVID-19, unless in the context of a clinical trial.

The Primary Care Collaborative and other nonprofit organizations are taking action to help remove barriers to reforming primary care delivery and payment, according to a presentation at the Primary Care Collaborative’s virtual meeting.

A fall prevention toolkit that engages hospitalized patients and their families was linked to fewer falls and injuries, according to research published in JAMA Network Open.

In a systematic review and meta-analysis, researchers found that the overall pooled lung cancer screening adherence rate among adults was 55%, “much lower” than rates reported in large randomized clinical trials.

Despite finding patients and providers have “positive perceptions” of nutrition therapy in chronic kidney disease, researchers suggest the broad implementation of such programs may be limited due to cost-related factors.

In an updated recommendation, the U.S. Preventive Services Task Force stated that medium- and high-intensity counseling for dietary and physical activity behaviors may be beneficial among all adult patients with high BP and/or dyslipidemia.

We are seeing an enormous rise in COVID-19 cases, but as we continue to focus on controlling the pandemic, it is vital that we prevent outbreaks of other vaccine-preventable infectious diseases.

A study conducted at a hemodialysis center in Paris suggests implementation of a screening procedure to test for COVID-19 may benefit patients and staff by enabling asymptomatic individuals to be identified and subsequently isolated.

Contending that “no clear guidance exists” regarding depression screening for patients with kidney failure, researchers determined there is also limited research assessing the accuracy of available tools.